Replies to post #252180 on Biotech Values

[DewDiligence]

FDA approves PFE, MRNA COVID vaccines targeting KP.2 variant:

https://finance.yahoo.com/news/pfizer-biontech-receive-u-fda-181500674.html (PFE)

https://finance.yahoo.com/news/moderna-receives-u-fda-approval-174700629.html (MRNA)

NVAX’s updated COVID vaccine is not ready yet.

[DewDiligence]

NVAX—FDA grants EUA for JN.1 COVID vaccine:

https://www.prnewswire.com/news-releases/fda-authorizes-updated-novavax-covid-19-vaccine-to-better-protect-against-currently-circulating-variants-302235235.html

Note that the PFE and MRNA updated COVID shots recently approved by the FDA target the KP.2 variant rather than JN.1 (#msg-174969836). This distinction probably has little consequence, however.

See #msg-174969866 for related info.